FALSE PHARMACORESISTANCE - A TRUE PROBLEM.

Area of Science:

• Neurology
• Clinical Epilepsy Management

Background:

• Pharmacoresistant epilepsy presents significant challenges for patients, families, and healthcare systems.
• Accurate diagnosis is essential, requiring thorough evaluation of all potential epilepsy causes.

Purpose of the Study:

• To highlight the concept and impact of false pharmacoresistance in epilepsy.
• To emphasize the importance of identifying and ruling out false pharmacoresistance to ensure timely and effective patient treatment.

Main Methods:

• Review of the definition and implications of false pharmacoresistance.
• Discussion of contributing factors including physician experience and patient adherence.

Main Results:

• False pharmacoresistance is characterized by poor seizure control not due to disease biology or drug inefficacy, but human error.
• This condition leads to real patient suffering and delays appropriate diagnosis and treatment.

Conclusions:

• False pharmacoresistance must be considered and ruled out in all patients with difficult-to-treat seizures.
• Identifying false pharmacoresistance is key to avoiding unnecessary procedures and initiating correct epilepsy management.